Molecular detection of human papillomavirus from abnormal cervical cytology of women attending a tertiary health facility in Ido-ekiti, southwest Nigeria
- PMID: 27582634
- PMCID: PMC4996045
Molecular detection of human papillomavirus from abnormal cervical cytology of women attending a tertiary health facility in Ido-ekiti, southwest Nigeria
Abstract
Background: Human papillomavirus (HPV) has been implicated as one of the principal causes of cervical cancer, which is the second highest cause of cancer deaths among Nigerian women.
Objective: This study was aimed at determining the presence of HPV DNA in abnormal cervical cytology of a group of women who were screened using Papanicolaou staining technique.
Methodology: A total of 200 women attending the Obstetrics and Gynaecology clinic of the Federal Teaching Hospital, Ido-Ekiti, were screened by means of conventional Pap smear screening, while positive samples underwent molecular analyses by means of DNA isolation techniques and polymerase chain reaction (PCR).
Result: Results revealed that 14 (7%) of the subjects were positive for abnormal cytology. Abnormalities found among the subjects included: low-grade squamous intraepithelial lesions (LSIL), which constituted 50% of the total abnormal smears, high-grade squamous intraepithelial lesion (HSIL) and atypical squamous cells of undetermined significance (ASCUS), which were 28.6% and 21.4%, respectively. Molecular analyses showed that all the samples from abnormal cervical cytology subjected to HPV DNA extraction and gene amplification contained HPV DNA.
Conclusions: The high prevalence of HPV DNA in abnormal cytology gives credence to the fact that the presence of HPV is a critical indicator of the development of cervical cancer. Thus more effort should be put into vaccine production and distribution in order to reduce the incidence of cervical cancer in Nigeria.
Keywords: Cervical cytology; HPV DNA; women.
Figures


Similar articles
-
Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.Clin Epigenetics. 2016 Sep 13;8(1):96. doi: 10.1186/s13148-016-0263-9. eCollection 2016. Clin Epigenetics. 2016. PMID: 27651839 Free PMC article.
-
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.JAMA. 1999 May 5;281(17):1605-10. doi: 10.1001/jama.281.17.1605. JAMA. 1999. PMID: 10235153
-
Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.J Gynecol Oncol. 2018 Jan;29(1):e14. doi: 10.3802/jgo.2018.29.e14. J Gynecol Oncol. 2018. PMID: 29185272 Free PMC article.
-
Worldwide burden of cervical human papillomavirus (HPV) in women over 50 years with abnormal cytology: a systematic review and meta-analysis.BMJ Glob Health. 2025 Apr 2;10(4):e017309. doi: 10.1136/bmjgh-2024-017309. BMJ Glob Health. 2025. PMID: 40180432 Free PMC article.
-
Human papillomavirus infections in primary care.Clin Med Res. 2007 Dec;5(4):210-7. doi: 10.3121/cmr.2007.751. Epub 2007 Dec 17. Clin Med Res. 2007. PMID: 18086908 Free PMC article. Review.
Cited by
-
The pattern of human papillomavirus infection and genotypes among Nigerian women from 1999 to 2019: a systematic review.Ann Med. 2021 Dec;53(1):944-959. doi: 10.1080/07853890.2021.1938201. Ann Med. 2021. PMID: 34124973 Free PMC article.
-
HPV-16 lineages among women in Africa: a systematic review with meta-analysis.Syst Rev. 2025 Jul 5;14(1):140. doi: 10.1186/s13643-025-02891-3. Syst Rev. 2025. PMID: 40618100 Free PMC article.
-
Prevalence and Type Distribution of Human Papillomavirus Recovered from the Uterine Cervix of Nigerian Women: A Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev. 2020 Oct 1;21(10):2837-2846. doi: 10.31557/APJCP.2020.21.10.2837. Asian Pac J Cancer Prev. 2020. PMID: 33112538 Free PMC article.
-
High risk human papilloma virus (HPV) common among a cohort of women with female genital mutilation.Afr Health Sci. 2019 Dec;19(4):2985-2992. doi: 10.4314/ahs.v19i4.19. Afr Health Sci. 2019. PMID: 32127873 Free PMC article.
References
-
- World Health Organization. (2008). Country Strategy: Federal Republic on Nigeria 2002-2007, WHO, Regional office for Africa, Brazzaville. Available at: http://www.who.int/countries/nga/about/ccs_strategy02_07.pdf [Accessed 10/06/2015].
-
- Parkin DM, Pisani P, Brary F. The global health burden of infection associated cancer. Int J Cancer. 2006;118:3030–3114. - PubMed
-
- Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group, author. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002;359:1093–1101. - PubMed
-
- Kjaer SK, Chackerian B, Brule AJ, Svare EI, Paull G, Walbomers JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse) Cancer Epidemiol Biomarkers Prev. 2001;10:101–106. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials